Success against sickle-cell would be “the first genetic cure of a common genetic disease” and could free tens of thousands of Americans from agonizing pain

Quick Read

The disease may be among the first to be treated with the novel gene-editing tool

Quick Read

So far, gene therapy has only treated rare disorders. Now, for the first time, it has been used to treat a boy with sickle cell disease, a common genetic disease

Quick Read

Researchers have cleared the last scientific hurdle to a clinical trial of gene therapy to cure sickle cell disease, they reported on Tuesday, fueling hopes that they will begin enrolling patients early next year. But they dodged a bullet

Quick Read

Q & A with Johns Hopkins Catalyst Award Winner Carlton Haywood Jr about his intervention designed to improve healthcare provider attitudes and beliefs about patients with sickle cell disease

Read More

Bioethics scholar and sickle cell disease researcher Carlton Haywood Jr. has been recognized by Ebony Magazine on its Power 100 list

Read More

Berman Institute Scholars launch a curriculum for training diverse healthcare workers to apply palliative care principles to pediatric patients suffering from sickle cell disease and Duchenne muscular dystrophy

Read More

Sickle cell disease patients are less likely to follow physician recommendations when they perceive discrimination, study finds. Authors include our Carlton Haywood Jr, and Mary Catherine Beach

Read More